e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about OncoBeta GmbH
Recent news which mentions OncoBeta GmbH
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
July 11, 2023
Tickers
EPIC
Tags
Germany
Health
Non/melanoma skin cancer
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
Medical
Squamous Cell Carcinoma
Rhenium/188
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Research
Australia
Science
From
PRLog
South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
December 22, 2022
Tags
Basal Cell Carcinoma
NMSC therapy
EPIC/Skin
From
PRLog
'Spot Detective' – Check your spots this summer
November 22, 2022
Tags
New South Wales
Skin Check
OncoBeta GmbH
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
Rhenium/SCT
Non/invasive
Single/session
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Medical
Rhenium/188
Rostock
From
PRLog
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
Tags
Medical
Squamous Cell Carcinoma
Rhenium/188
From
PRLog
OncoBeta launches International Registry for Non-Melanoma Skin Cancer
November 24, 2021
Tags
Rhenium/188
Avion Medical
Medical
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.